|
Title |
Prevalence and risk factors for drug-induced cutaneous reactions among hospitalised patients: A retrospective study
|
|
Authors |
Vineet Kumar Sahu1, Supriya Shakya2, Anshuli Trivedi3 & Durgesh Sonare4,*
|
|
Affiliation |
1Department of Dermatology, Venereology & Leprosy, People’s College of Medical Sciences & Research Centre, Bhopal, Madhya Pradesh, India; 2Department of Dermatology, Venereology and Leprosy, NSC GMC, Khandwa, Madhya Pradesh, India; 3Department of Community Medicine, Gandhi Medical College, Bhopal, Madhya Pradesh, India; 4Department of Dermatology Venereology and Leprosy, NSC GMC, Khandwa, Madhya Pradesh, India; *Corresponding author
|
|
|
Vineet Kumar Sahu - E-mail: vineetkumarsahu3feb@gmail.com
|
|
Article Type |
Research Article
|
|
Date |
Received October 1, 2025; Revised October 31, 2025; Accepted October 31, 2025, Published October 31, 2025
|
|
Abstract |
One of the most frequent adverse medication events seen in hospitalized patients is drug-induced cutaneous response (DICR). Hence, 143 inpatients that experienced dermatological symptoms as a result of pharmaceutical treatment were assessed in this retrospective investigation. Maculopapular rashes were the most common appearance and the two main medication classes implicated were antibiotics and anticonvulsants. There were notable correlations seen with advanced age, polypharmacy and a history of medication allergies. Early detection of high-risk profiles can improve patient safety and pharmacovigilance. |
|
Keywords |
Retrospective studies, polypharmacy, dermatological toxicity, hypersensitivity, hospitalized patients, medication-induced cutaneous reactions, adverse drug reactions, risk factors.
|
|
Citation |
Sahu et al. Bioinformation 21(10): 3461-3464 (2025)
|
|
Edited by |
A Prashanth
|
|
ISSN |
0973-2063
|
|
Publisher |
|
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|
|
|